Evaluation of Recombinant Invasive, Non-Pathogenic Eschericia Coli as a Vaccine Vector Against the Intracellular Pathogen, Brucella
Journal of Immune Based Therapies and Vaccines
doi 10.1186/1476-8518-7-1
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2009
Authors
Publisher
Springer Science and Business Media LLC